BTK-IN-17 (compound 36R) is a selective and orally activeBTK inhibitor with an IC50 value of 13.7 nM. BTK-IN-17 decreases the expression of p-BTKY223 and p-PLCgamma2Y1217. BTK-IN-17 shows anti-inflammatory effects[1].
Molecular Weight:
465.51
Formula:
C26H23N7O2
Target:
Btk
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted